Specific antigens expressed by cancer cells can be recognized by CD4+ memory activated T cells.18 CD8+ T cells can recognize and directly kill cancer cells by inducing apoptosis or cell death.20 The results indicate that patients categorized under the high-risk group are likely to exhibit a more favorable response to immunotherapy as compared to those in the low-risk group who may benefit from alternative therapeutic options. Here, CD8A is linked to cancer.